Merck names new vice president to Investor Relations Team

KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Peter Dannenbaum has been promoted to vice president, Investor Relations, effective Aug. 19, 2019. Teri Loxam, senior vice president, Investor Relations and Global Communications, will be leaving Merck to become chief financial officer of SQZ Biotech.

“Merck has benefited from Teri’s leadership and skilled and principled approach to communicating with its many constituencies including those in the financial community. She will be missed personally and professionally,” said Kenneth C. Frazier, chairman and chief executive officer, Merck. “She leaves behind a capable and experienced investor relations team under the leadership of Peter Dannenbaum.”

Mr. Dannenbaum joined Merck’s investor relations team in July 2017. Prior to this, Mr. Dannenbaum was a healthcare-focused portfolio manager and the director of research at CDPQ New York, a subsidiary of the Caisse de Depot et Placement du Quebec, for nine years. Mr. Dannenbaum also served as a healthcare analyst and portfolio manager at Morgan Stanley Investment Management and at John A. Levin & Company.